Furthermore, the Bmi-1 mRNA transcript levels are higher in plasma from breast carcinoma patients than in healthy controls, and this amplification of Bmi-1 is predictive of poor clinical outcome (Silva et al., 2007). This evidence concerns the gene BMI1 and breast carcinoma.